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Transitional cell carcinoma aﬀecting the upper urinary tract, though uncommon, constitutes a serious urologic disease. Radical
nephroureterectomy remains the treatment of choice but has undergone numerous modiﬁcations over the years. Although the
standard technique has not been deﬁned, the laparoscopic approach has gained in popularity in the last two decades. The most
appropriate oncological management of the distal ureteral and bladder cuﬀ has been a subject of much debate. The aim of the
nephroureterectomy procedure is to remove the entire ipsilateral upper tract in continuity while avoiding extravesical transfer of
tumor-containingurineduringbladdersurgery.Amyriadoftechnical modiﬁcationshavebeendescribed.Inthisarticle,wereview
the literature and present an overview of the options for dealing with the lower ureter during radical nephroureterectomy.
Copyright © 2009 Shalom J. Srirangam et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Primary urothelial carcinoma of the upper urinary tract
accounts for about 5% of all renal and urothelial malig-
nancies. Though relatively uncommon, the incidence of
upper tract transitional cell carcinoma (TCC) appears to
be slowly increasing [1–3]. While alternative therapies, such
as endoscopic ablation/resection and segmental ureteral
resection, have been adopted, radical nephroureterectomy is
considered the ideal treatment for upper tract TCC.
Le Dentu and Albarran performed the ﬁrst complete
open nephroureterectomy (ONU) for upper tract TCC in
1898 [4], but it was Kimball and Ferris in 1934 who
established the need for complete removal of the ipsilateral
renal tract on ﬁnding a high incidence of tumor in the
remaining ureter after simple nephrectomy for upper tract
TCC [5]. Upper tract TCC is frequently multifocal, has
a higher rate of ipsilateral ureteral recurrence, is often
associated with higher grade disease (42–47% grade 3; 18–
48% grade 2) and, therefore, carries a poorer prognosis
compared to bladder TCC [6, 7]. Thus in the presence of a
normal contralateral upper tract, complete removal of the
ipsilateral kidney, ureter, and bladder cuﬀ remains the gold
standard treatment for large, high-grade, or invasive TCC.
T h ep r o c e d u r em a yb eu n d e r t a k e no p e no rl a p a r o -
scopically. The “standard” laparoscopic nephroureterectomy
(LNU) technique has not been deﬁned and continues to
evolve. Variations include utilization of a pure laparoscopic
technique versus a hand-assisted technique; transperitoneal
versus retroperitoneal; and a myriad of approaches to deal
with the lower ureter [8]. Indeed, the issue of the most
appropriate oncological management of the lower ureter and
bladder cuﬀ has been the most debated and controversial
aspect of this operation since McDonald et al. attempted to
lessen surgical morbidity by advocating endoscopic resection
of the distal ureter in 1952 [9]. Many approaches, varying
in technique and results, have been described in [8]. Irre-
spective of the adopted technique, the challenge is to ensure
adherence to principles of reproducibility of results, patient
safety,andoncologicaloutcomes.TCCismultifocalandeven
with a negative cystoscopy, up to a third of patients may have
viable persistent tumor within the bladder. Some patients
will have vesical or para-vesical recurrence due to urine
spillage and the primary focus of the nephroureterectomy
procedure remains to avoid extravesical transfer of tumor-
containing urine during bladder surgery. This is the key
feature of improvements in the surgical technique. In this
paper, we aim to discuss the dilemma of the distal ureter and
present an overview of the diverse modiﬁcations employed
in managing the distal ureter.2 Advances in Urology
1. Management of the Distal Ureter
The risk of tumor recurrence within the residual ureteral
stump/periureteral meatal region in cases of incomplete
upper tract removal is often cited as between 30 and 64%
[10–12]. Total excision of the entire ureter, including the dis-
tal ureter with its intramural portion, the ipsilateral ureteral
oriﬁce and bladder cuﬀ is mandatory and represents a
distinct portion of the case, whether an open or laparoscopic
approach to the kidney is used. Ideally, this is achieved by
removal of an en bloc, “closed system” specimen following
controlled occlusion of the ureteral oriﬁce. Continuity of the
specimen, though desirable, may be conceded to aid ease of
extraction as long as the distal ureter is ligated and divided
at tumor-free location. The key issue is to avoid extravesical
urine contact and adherence to these principles will reduce
risk of spillage or seeding of tumor cells.
The following techniques, along with some minor vari-
ations, have been advocated in order to accomplish distal
ureteral removal:
(i) “pluck” technique,
(ii) intussusception technique,
(iii) pure laparoscopy,
(iv) open resection.
2. Transurethral Resection of Ureteral Oriﬁce
(“Pluck” Technique)
This involves the transurethral disarticulation of the intra-
mural ureter along with the ureteral oriﬁce (UO) using
a standard resectoscope loop or Collin’s knife, usually
prior to performing the laparoscopic nephrectomy. The UO
is resected deep into extravesical fat allowing subsequent
“plucking” of the entire ureter from above. Though the
original intention was to decrease morbidity by avoiding a
second lower abdominal incision during open surgery, this
is a less compelling argument with laparoscopic surgery as
specimen extraction mandates a larger incision.
Following UO resection, the patient is put in the ﬂank
position for LNU. The kidney is mobilized along with the
ureter down to the level of the pelvic brim. Gentle traction
on the ureter should result in the removal of the entire length
of ureter down to the level of the detached distal ureter. An
indwelling Foley catheter is left in the bladder for at least
7 days. The major concern related to this technique is the
risk of tumor cell spillage into the retroperitoneum with
subsequent seeding and local recurrence.
A number of authors have published small retrospective
series employing the pluck technique and report no local
disease recurrences [13–15]. Palou et al. reported no local
recurrences after an average followup of 20 months in 31
patients with mainly high grade upper tract TCC [13].
In a large multicenter, ﬁve-institution study comprising
116 patients who underwent LNU, no diﬀerence in local
recurrence was noted between the various techniques of
distal ureteral removal at a median followup time of 25
months [14]. Geavlete et al. recently reported on 100 ONU
patients from a single center, the majority of whom (72
cases) had undergone a pluck transurethral detachment
with coagulation of the resected area [16]. The remainder
(28 cases) were managed by ureteral stripping. No local
recurrences were reported after a mean followup of 44
months.
Nevertheless, the propensity for urological malignan-
cies, including TCC, to seed is well recognized [17]. Not
surprisingly, therefore, local recurrence following a pluck
nephroureterectomy has been noted on many occasions,
often occurring early and with tragic consequences [18–22].
Ko et al. reported on 51 patients undergoing LNU with the
distal ureter being managed by either the open (n = 30)
or the pluck technique (n = 20) [23]. The transurethral
pluck was restricted to TCC located in the calices, renal
pelvis, and ureter proximal to the pelvic brim and produced
recurrence rates similar to those in an open fashion. Of note,
however, is that ﬁve patients had an unplanned incomplete
ureterectomy and four had tumor recurrences (three in the
form of metastatic disease).
Furthermore, utilizing the pluck technique is likely to
permit continued urine extravasation from the cancer-
bearing ureter [24, 25]. Additionally, due to the absence
of an identiﬁable marker within the detached distal ureter,
conﬁrmation of complete specimen removal is not possible,
raising the theoretical possibility of local recurrence in any
remaining portion of ureter [24].
2.1. Pluck Technique Modiﬁcations. Various modiﬁcations
on the pluck theme have been described in an attempt to
minimize tumor spillage. Tan et al. advocated completion of
the laparoscopic nephrectomy ﬁrst with the clipping of the
ureter to prevent distal migration, followed by transurethral
Collin’s knife mobilization of the distal ureter and bladder
cuﬀ [8]. Recently, a novel technique has been described
involving an initial partial circumscribing of the bladder cuﬀ
withaCollin’sknifewitha1cmmarginaroundtheipsilateral
ureteral oriﬁce [26]. A preformed PDS Endoloop (Ethicon,
Sommerville, NJ, USA) is then passed through the cystoscope
to ligate and occlude the ureteral oriﬁce. The bladder cuﬀ is
then completely circumscribed down to perivesical fat and
subsequentlyremovedenbloc followingkidneymobilization.
The Endoloop also acts as a marker ensuring complete
specimen removal. A similar procedure has been described
using a transurethrally placed 5-mm laparoscopic hem-o-lok
clip on the ureteral stump, as an alternative to the Endoloop,
to ensure a closed system [27]. Both these studies report no
pelvic tumor recurrences in the short term [26, 27].
2.2. Ureteral Unrooﬁng. The ureteral unrooﬁng technique has
been described and popularized by the Washington Univer-
sitygroup[28].Thiscanonlybeemployedintransperitoneal
LNU and brieﬂy comprises cystoscopic incision of the entire
anterior length of the intramural ureter; electrocautery to
the cut edges and ﬂoor of the intramural ureter; placement
of a 7.5 F occlusion ureteral balloon catheter in the renal
pelvis to prevent urine spillage; laparoscopic dissection of
the kidney and ipsilateral ureter down to the level of theAdvances in Urology 3
bladder and specimen detachment following placement of
an Endo-GIA stapler on the bladder cuﬀ. This technique
has the theoretical advantage of minimizing urine leakage
while maintaining a truly minimally invasive approach
and promoting ureteral identiﬁcation intraoperatively. It is
contraindicated in the presence of active ureteral or bladder
TCC. Other potential disadvantages include requirement
of ﬂuoroscopy, risk of injury to the contralateral ureteral
oriﬁceasthestaplerisapplied“blindly”andlongeroperating
times [8]. Employment of the stapler device has produced
hypothetical concerns relating to stone formation, tumor
recurrence within urothelium trapped in the staple line,
and the inability to visualize this area satisfactorily during
subsequent surveillance cystoscopic inspections. These com-
plications have not been reported to be a clinical problem.
The same investigators compared LNU in 25 patients (using
the unrooﬁng technique) and ONU performed in 17 cases
with a mean followup of 24 months and 43 months,
respectively [29]. LNU took twice as long as ONU, but
was associated with less pain, fewer complications, a shorter
hospital stay, and quicker convalescence. Although there was
no statistically signiﬁcant diﬀerence in the disease-speciﬁc
survival rate and proportion of bladder tumor recurrences,
concerningly, there were 3 retroperitoneal recurrences in the
LNU group. Whether this is due to surgical technique or the
high tumor grade in these patients in unclear from the study.
2.3. Pluck Technique in HALNU. HALNU oﬀers distinct
advantages when considering how best to manage the distal
ureter. Firstly, the requirement of a longer incision to
facilitate a hand port will allow improved access to the
bladder and distal ureter, oﬀering the surgeon the option of
either an extravesical approach, open transvesical cystotomy,
or detaching the ureter using a transurethral technique
[30]. In addition, the operator can facilitate dissection and
resection by providing gentle countertraction on the distal
ureter. Tumor spillage can be prevented by occlusion of the
distal ureter by a clip or the surgeon’s hand. Alternatives
to the endoscopic management of the distal ureter during
HALNU have been reported. Gonzalez et al. described a
technique implementing insertion of a laparoscopic trochar,
followed by introduction of a 24 F nephroscope allowing
an endoscopic Collin’s knife incision of the bladder cuﬀ
[31]. This is performed subsequent to dissection of the
kidney and ureter, and after clips have been placed on
the lower ureter. Alternatively, a similar technique may
be performed without the need for a bladder port or
patient repositioning [32]. Placement of the patient in a
modiﬁed dorsal lithotomy position will permit introduction
of a transurethral resectoscope to perform the bladder cuﬀ
incision. The oncological sequalae of this same group of
patients was recently published, and none of the 49 patients
had developed a pelvic recurrence after a mean followup
periodof10.6months[33].Notably,theauthorsemphasized
early ligation of ureter but did not routinely close the
bladder. Vardi et al. reported a novel modiﬁcation to this
technique by inserting a ﬂexible cystoscope per urethra and
a 5 F electrode (ACMI, Norwalk, Conn, USA) to incise a
circumferential 2-cm cuﬀ of bladder around the UO using
cutting and coagulating current [34]. Patient repositioning
after the nephrectomy is avoided and the bladder opening is
not closed. No pelvic recurrences were noted in their small
group of patients after a mean followup of 31 months.
In summary, therefore, pluck techniques are contraindi-
catedinthepresenceoflowerureteraltumorandwidespread
urinary tract carcinoma in situ. Coexistent bladder TCC
should preclude the situation, where the bladder is left
“open” with potential exposure of the perivesical tissues to
malignant-cell laden urine. Patients with previous pelvic
irradiation and active inﬂammatory conditions of the blad-
der are probably not ideal candidates for endoscopic proce-
dures. Blind pulling of the ureter is discouraged to minimize
ureteral tearing and the possibility of residual tissue. While
retrospective studies have not conﬁrmed the superiority of
the open over the pluck method, the oncologically safe
practice of maintaining a “closed” system is preferred and
retroperitoneal exposure to potentially tumor cell-laden
urine for any duration of time, in our opinion, is best
avoided.
3.IntussusceptionTechnique
This technique, ﬁrst described by McDonald in 1953, has
undergone various subsequent modiﬁcations around a cen-
tralthemeofureteralligationandremovaleitherbystripping
or intussusception [35]. Principles of this technique include
initial catheterization of the ureter using either a ureteral
catheter or a stone basket ligation and division of the ureter
as part of the renal mobilization, securing of the distal
ureter to the ureteral catheter/stone basket, transurethral
incision of the bladder cuﬀ, followed by removal of the distal
ureter by gentle traction on the catheter via the urethra
[8, 18]. The distal ureter intussuscepts into the bladder
and can either be removed transurethrally or via a small
lower midline incision and anterior cystotomy. A variety of
technical devices, including sutures, vein stripper, balloon
catheter, and double ligation, have been described in an
attempt to improve ureteral excision of the ureter [18, 36–
38].
Though its long-term safety during LNU has not been
investigated, even after 5 years’ followup, Clayman et al.
reported no pelvic tumor recurrences in 14 patients under-
going ureteral stripping during ONU [36]. This is conﬁrmed
in a literature review by Laguna and de la Rosette, who
compared the stripping and pluck techniques [18]. While
there were no reports of local disease recurrence in the
stripping group, this technique was associated with a 10%
complication rate (including retained ureters and catheter
breakage) resulting in an open conversion rate of between
9.5 and 12.5% in patients after diﬃcult extraction.
Since the ureter is transected, it is contraindicated for
ureteral tumors and primarily conﬁned to low-grade renal
pelvic tumors. Additionally, any cause for pelvic ﬁbrosis,
such as previous surgery or irradiation and retroperitoneal
ﬁbrosis, may further increase the risk of retention of ureteral
remnant. Bladder mucosa is exposed to ureteral mucosa with
the potential for seeding. Its main drawback is its failure4 Advances in Urology
to guarantee adequate excision of the intramural ureter and
bladder cuﬀ, potentially resulting in tumor recurrence, and
is thus unlikely to gain universal acceptance following LNU.
4. Pure Laparoscopic
A completely laparoscopic approach oﬀers distinct advan-
tages in terms of blood loss, postoperative pain, recovery
times, and equivalent short- and intermediate-term onco-
logic eﬃcacy. The kidney and ureter are mobilized in the
standard fashion and the distal ureter may be secured by one
of 2 main techniques:
(i) laparoscopic extravesical stapling of the distal ureter
[28, 39];
(ii) transvesical laparoscopic detachment and ligation
(Cleveland approach) [40, 41].
4.1. Laparoscopic Stapling. This method is usually combined
with a ureteral unrooﬁng procedure. The ureter is clipped
early and dissected caudally until it diverges to merge with
the detrusor muscle ﬁbers at the ureterovesical junction
(UVJ). Gentle traction on the ureter will tent up the wall
of the bladder at the UVJ enabling placement of a 12-mm
laparoscopic GIA tissue stapler (Endo-GIA; Auto-Suture,
Norwalk, Conn, USA) or a large hem-o-lok clip. If desired,
an ontable bladder ﬁll with saline/indigo carmine solution
may be performed to exclude extravasation and/or a delayed
cystogram is obtained before catheter removal. A more
recent trend has been to perform stapling of the bladder cuﬀ
as the initial step, followed by a transurethral resection of the
ipsilateral UO till the staple line is reached [8].
Laparoscopic stapling has manifest advantages. It may
help reduce operative time and facilitates a minimally
invasive procedure while maintaining a “closed” urinary
tract, thus preventing tumor spillage. There are, however,
numerous concerns related to staple usage. Deployment
of the stapler may prove awkward in the restricted pelvic
space. An error in judgment may result in either part of the
intramural ureter being left behind or inadvertent injury to
the contralateral UO. In addition, the stapled margin cannot
be assessed histologically. The Nagoya group reported stone
formation at the staple line in 3 (5.7%) of 53 patients at an
average of 20 months postoperatively [42]. Using a porcine
model, Venkatesh et al. investigated the viability of bladder
cells using 4 types of laparoscopic vascular and tissue stapler
devices [43]. Viable cells were noted within the staple line in
all cases and this could represent a potential risk for tumor
recurrence in patients.
Romero et al. compared long-term safety and oncologic
eﬃcacy of extravesical laparoscopic stapling (n = 12) with
the traditional transvesical open excision (n = 12) at nearly
4y e a r sf o l l o w u p[ 44]. An increased positive margin rate
(3 versus 0 patients) and local recurrence rate (2 versus
0 patients), and decreased recurrence-free interval were
noted in the laparoscopic stapled group compared to the
open group. However, none of these results was statistically
signiﬁcant probably owing to the small numbers. A number
of authors have compared the various methods to distal
ureteral excision and reported a higher incidence of positive
surgical margins (up to 25%) and local recurrence (up to
15%) in the pure LNU with laparoscopic stapling cohort
[25, 29, 45]. This highlights the need for meticulous removal
of the whole ureter, UO, and bladder cuﬀ. Contraindications
include presence of mid/lower ureteral and bladder TCC.
More recently, Tsivian et al. described a variation on the
laparoscopic stapling technique, using a 10-mm LigaSure
Atlas (Valleylab, Tyco Healthcare UK Ltd, Gosport, UK)
[46]. The bladder cuﬀ was excised laparoscopically in an
extravesical fashion using the LigaSure, without the need
for staples. There were 2 bladder recurrences distant from
the site of surgery but no reports of local recurrence in 13
patientsfollowedupfornearlyayear.Suturingofthebladder
following LNU may be performed by those skilled in this
technique.
4.2. Transvesical Laparoscopic Detachment and Ligation. This
novel technique of securing the distal ureter and bladder cuﬀ
using transvesically placed laparoscopic ports was described
by Gill et al. and is almost exclusively employed by the
Cleveland clinic group [40, 41]. In this modiﬁed “pluck”
procedure, a transurethral Collin’s knife incision of the
bladder cuﬀ is performed after placement of a catheter
into the aﬀected ureter. Simultaneously, two 5-mm balloon-
tipped ports are inserted suprapubically into the bladder.
The incised UO is tightly snared using a 5-mm Endoloop
(Ethicon, Cincinnati, Ohio, USA), preventing urine leakage
from the ureter. Traction on the incised bladder cuﬀ enables
the mobilization of 3-4cm of distal ureter into the bladder.
The entire ureter can then be pulled through cephalad
after radical nephrectomy and ureteral dissection. A bladder
catheter is left in situ for 1 week.
Theauthorsclaimthatthetransvesicaltechniqueadheres
to general oncological principles of complete and controlled
en bloc specimen extraction. The ureteral catheter and
Endoloop occlude the ureter, thereby reducing urine leakage.
An indwelling ureteral catheter may aid identiﬁcation and
mobilizationoftheureterduringthelaparoscopicprocedure.
Complete retrieval is conﬁrmed by visualization of the
Endoloop. However, this may be a diﬃcult technique to
master for most urologists and operating time is usually
lengthened by 60–90 minutes [24, 47]. Other criticism of
this approach includes the potential for irrigation ﬂuid
extravasation resulting in dilutional hyponatremia, the need
for patient repositioning, and the possibility of port-site
metastases. Contraindications include the presence of distal
ureteral TCC or concomitant bladder tumors, prior pelvic
surgery or irradiation and obesity [45].
LNU with the transvesical technique has been evaluated
againstONUinaretrospectiveseries[41].Gilletal.reported
that 27 patients who had undergone the former procedure
had statistically signiﬁcant superior results compared to the
latter (35 patents) technique with regards to surgical time,
blood loss, narcotic analgesia requirements, hospital stay,
convalescence, and complication rates. Bladder recurrence
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and no local retroperitoneal or port-site recurrence were
diagnosed in any patients. The same group reviewed their
outcomes in 60 patients following LNU, who had either had
a laparoscopic stapling (n = 12) or transvesical laparoscopic
detachment of the distal ureter (n = 36) [45]. Following a
mean followup period of 23 months, positive margins were
more common in the former group (25 versus 2.8%) as were
the rates of bladder recurrences at the ipsilateral ureteral
scar/oriﬁce (41.7 versus 13.9%), retroperitoneal recurrence
(8.3 versus 5.6%), and distant metastasis (25 versus 8.3%).
None of these diﬀerences was statistically signiﬁcant and
deﬁnitive conclusions are diﬃcult to derive from such small
retrospective series.
Recently, Cheng et al. described a similar technique
utilizingapneumovesicumtosecuretheUOandbladdercuﬀ
[48]. Following initial cystoscopy to exclude bladder tumors,
three 5-mm PediPorts (Tyco) are inserted suprapubically
into the bladder. Following the establishment of a carbon
dioxide pneumovesicum, the ipsilateral UO is closed using
a stitch and the bladder cuﬀ is incised down to fat using
diathermy scissors. The bladder defect is closed using
Polysorb sutures before completion of a standard 5-port
laparoscopic nephroureterectomy. The authors report on
a single case and propose that gas insuﬄation minimizes
tumor spillage/seeding and permits a superior endoscopic
view, even in the presence of bleeding, compared to liquid
endoscopy as in the Cleveland method.
5. Open Removal
The open technique (either 2-incision or extended single
incision) forms the standard against which all techniques are
measured. Typically performed after nephrectomy, it can be
performed through a lower midline, modiﬁed Pfannenstiel,
or Gibson incision. The lower ureter is clipped, dissected
free, and removed in continuity with the bladder cuﬀ.T h e
bladder cuﬀ may be secured extravesically (using a right
angle clamp) or via an anterior cystotomy. The en bloc
specimen is delivered through the same incision.
In the review of 252 patients performed by Hall et
al., 194 patients had undergone ONU with open bladder
cuﬀ excision for TCC and showed excellent long-term local
control [6]. Klingler et al. reported outcomes at a mean
followup period of 22 months in 19 patients who had an
LNU with open bladder cuﬀ excision versus 15 patients with
a standard ONU [49]. Only 1 patient in the LNU group,
with a high-grade, locally inﬁltrative, lymph node positive
ﬁnal histology (pT3b pN2 G3 TCC) had local recurrence.
There was no signiﬁcant diﬀerence in local recurrence rates
between the laparoscopic and open group.
Ar ecentmulticenterr etr ospectiv eBelgianstudyanalyzed
100 patients following LNU for TCC [50]. Of these, 55
patients had an open excision of the distal ureter while the
rest (45 patients) underwent a laparoscopic technique. Local
recurrence was noted in 13 out of 100 cases of which 6 of
55 cases (11%) had open distal ureter management and 7
of 45 (16%) laparoscopic handling of the distal ureter. The
investigators attribute the higher local recurrence rate to the
larger proportion of high grade disease being operated on.
The open technique is not without its pitfalls. The
“blind” extravesical clamping may compromise the con-
tralateral UO and does not inevitably guarantee adequate
bladder cuﬀ retrieval [51]. An anterior cystotomy must
be avoided in the presence of active bladder TCC as it
retains the potential to seed tumor into the extravesical
space. Furthermore early ligation/clipping of the ureter
during the nephrectomy part is advisable. Additionally, prior
pelvic surgery or irradiation and obesity may render the
open procedure more challenging. Notwithstanding these
potential concerns, the open approach to distal ureteral
removalisoncologicallysoundandminimizestumorspillage
and therefore has withstood the test of time [52]. An
open incision is often required for specimen extraction
and adds little to overall morbidity, while providing visual
conﬁrmation of complete upper tract resection. It also
enables accurate histological examination and reporting by
the pathologist. Patient repositioning is usually required but
notalwaysmandatory.Atourinstitution,thisisthepreferred
method of dealing with the distal ureter following LNU.
Table 1 summarizes the data from some of the studies (all
retrospective in design) comparing the diﬀerent techniques
of distal ureteral management and associated outcomes.
6. Open or Laparoscopic?
Given the uncommon nature of upper tract TCC, there is
a scarcity of prospective randomized studies with long-term
followupcomparingbothmodalitiesofnephroureterectomy.
The “gold standard” open surgery oﬀers excellent access but
at the expense of increased patient morbidity. Since being
ﬁrst described in 1991 by Clayman et al., increasing surgical
experience and equipment quality has seen LNU emerge as a
viable option with the express intention of minimizing sur-
gical morbidity without compromising oncology outcomes.
Rassweiler et al. performed a meta-analysis comparing
ONU and LNU, which included 1365 patients from 85
studies [55]. LNU was associated with a slightly longer
operating time (276.6 versus 220.1 minutes); signiﬁcantly
lowerbloodloss(240.9versus462.9mL);decreasedanalgesia
requirements and shorter hospital stay (not statistically
signiﬁcant in all included studies). There appeared to be
no signiﬁcant diﬀerence in complication rates, both minor
(12.9 versus 14.1%) and major (5.6 versus 8.3%) between
LNUandONU,respectively.Inaddition,bladderrecurrence,
local recurrence, distant metastases, and actual disease-free
two-year survival rates (75.2 versus 76.2%) were similar. It
is worth noting that caution is suggested in interpreting the
data from this meta-analysis as the majority of studies were
retrospective,nonrandomized,andlimitedbyshortfollowup
periods and variable outcome measures.
Further, recent smaller retrospective comparisons by
McNeill et al. (n = 67) [56], Tsujihata et al. (n = 49) [53],
Taweemonkongsap et al. (n = 60) [54], Rouprˆ et et al. (n =
46)[57],andManabeetal.(n =224)[58]havedemonstrated
parity between ONU and LNU when comparing oncological
parameters over a shorter followup period (1–3 years). In
a similar study, but with 7-year outcome data, LNU was
noted to have a similar local recurrence rate (8 versus6 Advances in Urology
Table 1: Summary of perioperative results and oncological outcomes for the diﬀerent distal ureteral management techniques from selected
larger studies. (ND: no data; LOS: length of stay; f/u: mean followup).
f/u n Procedure
type
Number of
complica-
tions of
distal
ureter
technique
Median
LOS (days)
Positive
margins
Bladder
recurrence
(%)
Pelvic
recurrence
(no)
No. of
cancer-
speciﬁc
deaths
Pluck technique
Palou et al., 1995 [13] 20 31 ONU 1 ND ND 35 0 2
Ubrig et al., 2004 [15] 44 18 ONU 1 11 ND 50 0 5
Geavlete et al., 2007 [16] 44 72 ONU 2 10 ND 24 0 9
Laguna and de la Rosette,
2001 (meta-analysis) [18]
n/a 129 ONU/LNU 3 ND ND 24 4 ND
Ko et al., 2007 [23] 22 19 ONU/LNU 0 7.3 0 26 1 1
Modiﬁcation of Pluck technique
Agarwal et al., 2008 [26] 15 13 LNU 0 7.3 0 38 0 1
Ureteral derooﬁng
Shalhav et al., 2000 [29] 24 24 LNU 2 6.1 ND 23 3 ND
Pluck in HALNU
Wong and Leveillee, 2002 [32] 8 14 HALNU ND 2 ND 14 ND ND
Laparoscopic extravesical ureteral stapling
Jarrett et al., 2001 [39] 24 2 5 L N U 0414 8 0 2
Laparoscopic transvesical ureteral ligation
Gill et al., 2000 [41] 11 42 LNU 1 2.3 3 24 0 2
Open distal ureteral excision
Klingler et al., 2003 [49] 22 19 LNU 0 8.1 0 ND 0 ND
Tsujihata et al., 2006 [53] ND 49 ONU/LNU 0 4 ND 31 0 2
Taweemonkongsap et al., 2008
[54]
27 60 ONU/LNU 0 9 ND 37 3 8
15.4%), bladder recurrence rate (28 versus 42%), and 5-year
metastases free survival rate (87.2 and 82.1%) compared to
ONU [59].
Port-site seeding following LNU remains a concern but
is fortunately rare if appropriate surgical techniques are
adopted and have been mainly conﬁned to individual case
reports [60, 61].
Hand-assisted laparoscopic nephroureterectomy referred
to as (HALNU) is often seen as a compromise between
the open and laparoscopic technique. Arguments in its
favor include a shorter learning curve, facilitates tactile
feedback and the eventual requirement of a longer incision
following LNU for specimen extraction. In a prospective, but
nonrandomized study with 27 subjects, patients undergoing
an HALNU could expect a quicker discharge from hospital,
faster recovery, and fewer complications with an equivalent
intermediate-term oncologic outcome compared to the open
approach [62]. On the other hand, HALNU took longer
and was more expensive. Other studies evaluating ONU and
HALNU have conﬁrmed an overall equivalence with regards
to cancer control in the short term [30, 63].
Clearly, in the absence of prospective, randomized stud-
ies comparing ONU, LNU, and HALNU, it is injudicious
to draw robust conclusions regarding the superiority of
one technique over the other. Nevertheless, though radical
ONU still represents the gold standard for upper tract TCC,
laparoscopicnephroureterectomyappearstooﬀertheadvan-
tages of minimally invasive surgery without deteriorating the
oncological outcome in most cases.
7. Conclusion
TCC of the upper urinary tract, though rare, constitutes a
serious urological disease. Even though it is curable in its
early stages, there has been little improvement in disease-
speciﬁc survival in high-risk patients over the last three
decades. Radical nephroureterectomy, with en bloc removal
of the entire ureteral length and cuﬀ of bladder, remains
the procedure of choice, and the technique has undergone
numerous modiﬁcations in recent years. The integration of
laparoscopy into urological practice has seen LNU emerge as
a viable option for the management of upper tract TCC.
Given the relative rarity of the disease and a lack of
robust multicenter eﬀort, it is unlikely that the issue of
LNU versus ONU for upper tract TCC will be resolved in a
prospective randomized manner. Nevertheless, a multitudeAdvances in Urology 7
of small prospective studies with intermediate followup
have clearly demonstrated the beneﬁts of minimally invasive
surgery (lesser morbidity, quicker recovery, better cosmesis)
associated with LNU, along with comparable oncological
eﬃcacy in the hands of appropriately trained and experi-
enced laparoscopic urologists. Long-term data from these
studies would be beneﬁcial.
The issue of the distal ureteral remains unresolved,
and number and complexity of available techniques will
undoubtedly continue to evolve. The existing data does
not conﬁrm the overwhelming superiority of one technique
over the other. Each method has its distinct advantages and
disadvantages and it is essential that the responsible surgeon
adopts a meticulous, safe, reproducible, and oncologically
sound technique.
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